BIIB : Analysis & Opinions

  1. 6 Stocks to Own While the Fed Hikes Rates

    October 14, 2015
    Understand what happens if the Federal Reserve increases interest rates. Learn about the top six stocks to own if the Fed ...
  2. Weakness In Biotech Will Likely Continue

    October 1, 2015
    You can breathe easy with your biotech holdings--assuming you aren't counting on them to make you rich.
  3. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    August 27, 2015
    Between the July 31 and August 14 settlement dates, the number of shares short in the leading biotech and emerging pharmaceutical ...
  4. Key Financial Ratios to Analyze Biotech Companies

    August 20, 2015
    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies ...
  5. Top 3 Biotech ETFs

    August 14, 2015
    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term ...
  6. ETF Analysis: iShares NASDAQ Biotechnology

    August 7, 2015
    Learn about the iShares Nasdaq Biotechnology exchange-traded fund, which offers one of the most diversified ways of investing ...
  7. Does a Safe Biotechnology Stock Exist?

    June 24, 2015
    Seasoned investors know that the biotechnology sector in inherently risky business.
  8. 3 Reasons That Biogen's Shares Could Rise

    June 16, 2015
    Biogen (NASDAQ: BIIB) is on a roll thanks to the fast growth of its multiple sclerosis drug Tecfidera, but this oral drug ...
  9. Biogen's Biosimilars Program Leaps Forward

    June 11, 2015
    Until recently, biologic drugs were insulated against generic competition because they are difficult to duplicate, and no ...
  10. How Does Biogen Make its Money?

    June 2, 2015
    Biogen is a healthy biotechnology company producing a stream of illness-fighting drugs. Its big sellers treat MS, and it ...
  11. 3 Things Biogen's Management Wants You to Know

    May 19, 2015
    Last month, Biogen (NASDAQ: BIIB), one of biotech's biggest companies, updated investors with its first-quarter financial ...
  12. Is This Biogen's Next Billion-Dollar Blockbuster?

    May 11, 2015
    Biogen (NASDAQ: BIIB) recently announced that its next-generation multiple sclerosis drug Zinbryta has been submitted for ...
  13. Young Investors: Should You Care About Dividends?

    May 5, 2015
    If you're a young investor, you may want to consider a non-traditional approach to investing.
  14. Biogen's Tecfidera Loses Some Luster

    April 30, 2015
    Since winning FDA approval in 2013, Biogen's (NASDAQ: BIIB) Tecfidera has become the most widely prescribed oral multiple ...
  15. Why These May Be the Top 4 Growth Stocks of 2015

    April 17, 2015
    These four stocks have high upside potential in 2015.
  16. Biogen Earnings Preview: 3 Key Factors to Monitor

    April 14, 2015
    For the better part of a decade, Biogen (NASDAQ: BIIB) could simply do no wrong by its shareholders. Whereas the S&P ...
  17. Should Biogen Be Afraid of This Upstart?

    April 13, 2015
    Biogen (NASDAQ: BIIB) is a biotech Goliath that is best known for its dominant leadership in the treatment of multiple sclerosis. ...
  18. Biogen Goes Generic

    April 9, 2015
    "If you can't beat 'em, join 'em" appears to be part of Biogen's (NASDAQ: BIIB) new mantra. Biogen's Rituxan is approved ...
  19. Can Biogen Change How We View Alzheimer's Disease?

    March 25, 2015
    As the global population gets increasingly older, Alzheimer's disease is going to get increasingly prevalent. As a result, ...
  20. Is It Time to Consider Selling Biogen?

    March 24, 2015
    Is it hot in here, or is it just Biogen (NASDAQ: BIIB)? Fresh off an official name change to "just" Biogen (from Biogen ...
  21. Is Biogen Worth Owning for the Long Haul?

    March 20, 2015
    Biogen Idec (NASDAQ: BIIB) is one of the planet's largest biotechnology companies and a key player in this industry that ...
  22. Are These Biogen Idec's Next Blockbusters?

    March 9, 2015
    Biogen Idec is already a company worth watching, but it’s recently launched hemophilia drug could become its next billion-dollar ...
  23. What Drugs Could Boost Biogen Idec’s Sales?

    March 3, 2015
    Bet against biotechnology giant Biogen Idec and it's likely to sting -- at least that has been the message over the last ...
  24. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  25. Adapt The 50-Day EMA To Enhance Your Trading

    January 14, 2015
    The 50-day EMA has numerous applications in price prediction, position choice & strategy building
  26. Biotechnology Stocks To Keep on the Radar

    April 23, 2014
    Health care is showing a resurgance, lead by biotechnology. Here are the opportunites to watch.
  27. Four Breakout Stocks To Watch

    February 19, 2014
    These biotechnology and pharmaceutical stocks continue to put in new highs, but indicators are diverging.
  28. Focusing on Healthcare and Financials this Week

    November 25, 2013
    Health Care and Financials dramatically outpaced the other sectors last week as the S&P 500 created a new high . With only ...
  29. A Strong Prognosis For Healthcare Stocks

    November 19, 2013
    Despite the healthcare sectors recent torrid run, there’s still plenty to like about stocks in the industry. Aside from tailwinds ...
  30. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  31. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    September 14, 2013
    Declining short interest in Alexion Pharmaceuticals (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical ...
  32. Can Sanofi Investors Just Blame It On Rio?

    August 6, 2013
    Can Sanofi Investors Just Blame It On Rio? By Stephen D. Simpson, CFA Sanofi (NYSE: SNY) was supposed to be a relatively ...
  33. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  34. Elan Shareholders Bring Management To Heel

    June 17, 2013
    The rejection of Elan management's proposed transactions ought to accelerate the sale of the company.
  35. After A Good Run, Novartis Looks Fairly Valued

    June 12, 2013
    Novartis is a well-balanced, high-quality pharma with growth credentials, but also a fair valuation today.
  36. 10 Picks from 2 Strong Sectors

    June 10, 2013
    As we enter the bumpy summer months, large-cap US domestic stocks and health-care names are on Louis Navellier's list, and ...
  37. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  38. Strategy for Trading High Flying Healthcare Stocks

    April 17, 2013
    Over the past week, month and three months, the healthcare sector has been the top performer.
  39. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  40. Rising Trend Channel Breakouts - Acceleration Or Top?

    July 4, 2012
    These stocks have been within rising trend channels, but recently have broken the trend channel to the upside. Such a breakout ...
  41. Biotech ETFs Hitting Highs

    May 17, 2012
    Biotech ETFs are hitting all-time highs and XBI looks like the best of the group. Because the ETF is already up 25% in 2 ...
  42. Best S&P 500 Stocks Of 2011

    January 5, 2012
    The best performing stocks in the S & P 500 in 2011 were concentrated in the energy and health care sectors.
  43. Can The Big Gains Continue Into 2012?

    January 3, 2012
    Learn the opportunities and risks that await some top performers in 2012.
  44. Sanofi's Investment Prospects

    December 21, 2011
    Sanofi has emerged as an unheralded value in pharmaceuticals.
  45. 2011's Highest Performing S&P500 stocks

    December 15, 2011
    Check out 2011's highest-performing S&P 500 stocks.
  46. How to Use Technicals to Trade ETFs

    November 7, 2011
    A couple of health-care growth names are performing well after earnings, says Ken Shreve, who also shares his methodology ...
  47. Biogen Idec Has Built A Valuable Franchise

    November 1, 2011
    Biogen Idec is a go-to name in MS that carries a lot of value. A credible buy for those with longer horizons.
  48. Abbott Labs Joins The Separation Movement

    October 24, 2011
    Abbott is joining the separation movement that is sweeping across corporate America. The company plans to break into a medical ...
  49. Betting On Healthcare's Growth Engine

    August 17, 2011
    In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
  50. 6 Overbought Stocks To Watch

    April 25, 2011
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  51. Human Genome Takes A Big Step Forward

    November 17, 2010
    HGSI's prospects get a big boost from a panel approval.
  52. 4 Companies That Should Have Sold Out

    September 9, 2010
    When company management gets unreasonably stubborn and refuses a merger or buyout, shareholders often pay the price.
  53. Biotech Stocks Ready Ready To Break Out

    September 7, 2010
    Biotech Stocks Ready Ready To Break Out
  54. Another Setback For Roche Is Bad News For ImmunoGen

    August 27, 2010
    Roche suffers another setback to its key cancer franchise, while ImmunoGen faces a major delay in royalty payments.
  55. Big Pharma's Big Problem

    August 16, 2010
    Big Pharma's best patents are expiring, but it may be able to reinvent itself through acquisitions.
  56. Biotech Bargains

    June 17, 2010
    High-growth biotech stocks are now priced like value plays.
  57. 3 Great But Misunderstood Stocks

    May 4, 2010
    Is a lack of understanding of these 3 stocks causing some investors to miss the boat?
  58. Cash Rich, No Debt Stocks

    February 8, 2010
    Anytime you can find a company with lots of cash and little or no debt, it's worth a closer look.
  59. Short The Weak Stocks

    May 11, 2009
    Retailers often flock to short high-profile stocks that have gained in price during a downturn, but they may have better ...
  60. Is Now The Time To Buy Pharmaceuticals?

    May 5, 2009
    Despite the recession, the pharmaceutical sector continues to show strong year-over-year earnings results and demand worldwide.
  61. Money Flowing Into Biotech Stocks

    January 12, 2009
    Institutions have their eyes on biotech stocks. Does this sector have your attention?
Trading Center